PRAGUE—Therapy with bardoxolone, an oral antioxidant inflammation modulator, is associated with improved kidney function out to one year in patients with advanced chronic kidney disease (CKD) and type 2 diabetes, according to investigators.
BERLIN—The Acute Kidney Injury Network (AKIN) criteria for acute renal failure (ARF) better predicted survival over a period of 90 days in a study of hospitalized patients with cirrhosis when compared with current criteria, according to a study presented at the 46th Annual Meeting of the European Association for the Study of the Liver.
ACE inhibitor of ARB use decreased progression risk in patients with macroalbuminuria at baseline.
Researchers have found a seasonal variation in urinary albumin-to-creatinine ratio (UACR) in Japanese patients with type 2 diabetes and early nephropathy, with the highest values in winter and the lowest in summer.
